Investor Stryker Corp
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Stryker Corp . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2018-03-08 13D/A ENTL / Entellus Medical, Inc. 30,027,323 30,027,323
2018-02-28 13D ENTL / Entellus Medical, Inc. 9,753,548 30,027,323
2017-12-18 13D ENTL / Entellus Medical, Inc. 9,753,548
2014-02-14 13G/A SYK / Stryker Corporation 20,104,700
2014-02-05 13D/A PSTX / Poseida Therapeutics, Inc. 11,297,433
2014-01-10 13D PSTX / Poseida Therapeutics, Inc. 12,540,397